Navigation Links
Carnegie Mellon scientists develop fluorescent proteins for live cell imaging, biosensor design
Date:2/6/2008

PITTSBURGH Scientists at Carnegie Mellon Universitys Molecular Biosensor and Imaging Center have developed new fluorogen activating proteins (FAPs) that will become a key component of novel molecular biosensor technology being created at Carnegie Mellon. The FAPs, which can be used to monitor biological activities of individual proteins and other biomolecules within living cells in real time, are described in the February issue of Nature Biotechnology.

Carnegie Mellon scientists designed the FAPs to emit fluorescent light only when bound to a fluorogen, an otherwise non-fluorescent dye added by the scientists. This feature will allow biologists to track proteins on the cell surface and within living cells in very simple and direct ways, eliminating cumbersome experimental steps.

Scientists say the fluorogen activating proteins are especially useful for developing molecular biosensors, because FAPs allow researchers to not only see where the target protein is within the space of the cell, but also to see color changes when it becomes fluorescent. Color changes may reflect changes in the local environment of the protein, and allow quantitative sensing in real time of the biological activity of proteins and biomolecules that are in close proximity to each other.

Biologists often have a difficult time locating a target biomolecule inside living cells using other dye technologies because of background light given off by any unbound dye molecules. This background light obscures the biomolecules glow and therefore must be removed to successfully carry out the experiment.

The new FAP technology gives off light only when and precisely where the target biomolecule is present, enabling scientists to activate the fluorescence when needed to see exactly where in the cell the biomolecule is located. Scientists also can design fluorogens that can enter the cell and fluorogens that cant. When used with fluorogens that are excluded from the cell, the FAP technology provides an exceptionally selective biosensor for proteins at the outside of the cell surface.

The FAP is a specialized single chain antibody (scFv), a recombinant fragment of full-size antibody proteins that the human immune system uses to identify intruders like bacteria or viruses. The Carnegie Mellon scientists screened billions of scFvs to look for those that bound specifically to either of two fluorogens, malachite green and thiazole orange. The team found several scFvs that, when bound to the fluorogen, emitted bright fluorescent signals. They termed these scFvs fluorogen activating proteins.

These FAPs are the essential first step in developing molecular biosensors that will monitor dynamic changes occurring within cells, said Alan Waggoner, professor of biological sciences and director of the Molecular Biosensor and Imaging Center (MBIC). The ultimate goal is to put molecular biosensors based on FAP technology inside cells, but this current work is immediately useful. We have used the FAPs in conjunction with several fluorogens to visualize proteins at the cell surface and are now using the technology to image proteins inside cells.

The new FAPs are an extension of the genetic approach made popular by the advent of fluorescent proteins, such as green fluorescent protein (GFP), more than a decade ago. GFPs, once expressed in cells, are always aglow when visualized by scientists using special light sources and microscopes. The Carnegie Mellon team has taken GFP technology one step further with the novel FAPs and associated fluorogens, they can control fluorescence in space and time.

The beauty of our system is that we can make FAPs with genetic variations so that we can co-express distinct FAPs within a cell. We can also make synthetic variations of the fluorogen that have different fluorescent and binding properties. Together, these modifications will allows us to image multiple colors inside cells, enabling us to dynamically monitor several proteins and follow complex cellular functions, said Chris Szent-Gyorgyi, a research scientist at the MBIC who spearheaded the isolation of the FAPs.


'/>"/>

Contact: Jocelyn Duffy
jhduffy@andrew.cmu.edu
412-268-9982
Carnegie Mellon University
Source:Eurekalert

Related biology news :

1. Carnegie Mellon scientists develop nanogels that enable controlled delivery of carbohydrate drugs
2. Carnegie Mellon scientists investigate initial molecular mechanism that triggers neuronal firing
3. Carnegie Mellon scientist uses mass spectrometer to weigh virus particle, von Willebrand factor
4. Carnegie Mellon, Pitt Team to study psychosocial stress
5. Mellon awards Carnegie Grant for Ecological Monitoring in South Africa
6. Carnegie Mellon researchers to develop new drug delivery system
7. Carnegie Mellon students win contest
8. Novel mechanism for long-term learning identified by Carnegie Mellon researchers
9. U. Mass Medical School and Carnegie announce licensing agreements with Oxford BioMedica
10. UK scientists working to help cut ID theft
11. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
(Date:3/23/2017)... Mar. 23, 2017 Research and Markets has ... Analysis & Trends - Industry Forecast to 2025" report to ... ... a CAGR of around 8.8% over the next decade to reach ... analyzes the market estimates and forecasts for all the given segments ...
Breaking Biology News(10 mins):
(Date:4/19/2017)... and PUNE, India , April 19, 2017 /PRNewswire/ ... "Membrane Microfiltration Market: Global Opportunity Analysis and Industry Forecast, 2014-2022 ," the global ... $12,858 million by 2022, registering a CAGR of 9.6% from 2016 to 2022. ... ... ...
(Date:4/19/2017)... and WESTMINSTER, Colo. ... LLC ("Oxford"), an industry-leading specialty finance firm that ... services companies, today announced the closing of a ... Inc. ("Cerapedics") a privately-held orthobiologics company engaged in ... products for the treatment of orthopedic injuries. ...
(Date:4/19/2017)... , April 19, 2017   Thermo Fisher ... the multi-center Procalcitonin MOnitoring SEpsis (MOSES) Study have ... of Critical Care Medicine . Researchers from ... Severe Sepsis Patients: Results From the Multicenter Procalcitonin ... the B·R·A·H·M·S PCT (procalcitonin) assay to assess risk ...
(Date:4/18/2017)... ... April 18, 2017 , ... CallTower, an industry-leading ... Solution Provider. , Channel Partners program recognizes IT and telecom channel leaders who ... advocacy of the channel during transition and convergence. CallTower is the first provider ...
Breaking Biology Technology: